Enveric Biosciences's total assets for Q1 2025 were $5.10M, an increase of 65.52% from the previous quarter. ENVB total liabilities were $1.18M for the fiscal quarter, a -20.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.